ELI LILLY & Co is 656.0x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($1.093 T vs $1.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRDN | LLY |
|---|---|---|
| Market cap | $1.67 B | $1.093 T |
| US-listed rank | #2250 | #11 |
| Revenue (latest FY) | $70.85M | $65.18B |
| Net income (latest FY) | -$342.60M | $20.64B |
| Net margin | -483.6% | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 794 | 989 |
ELI LILLY & Co is 656.0x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($1.093 T vs $1.67 B).
In their latest fiscal years, Viridian Therapeutics, Inc.DE reported $70.85M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Viridian Therapeutics, Inc.DE and ELI LILLY & Co, or browse the full rankings.